购物车
- 全部删除
- 您的购物车当前为空
RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.
RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 20,500 | 10-14周 | |
50 mg | ¥ 27,300 | 10-14周 | |
100 mg | ¥ 35,500 | 10-14周 |
产品描述 | RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered. |
分子量 | 510.6 |
分子式 | C27H35FN6O3 |
CAS No. | 2171388-28-4 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容